Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article by Jeffrey Zwicker et al, published in The Lancet Haematology, adding:
“ROXI-CATH: targeting factor XI to prevent catheter-related thrombosis.
Presented at AHA26 and now published in The Lancet Haematology, this phase 2 randomized, double-blind, placebo-controlled trial evaluates amrecibart and cenvacibart for thromboprophylaxis following PICC placement, an important clinical challenge.
Looking forward to seeing how this research advances catheter-related thrombosis prevention.”
Title: Amrecibart and cenvacibart for the prevention of catheter-related thrombosis (ROXI-CATH): a double-blind, randomised, placebo-controlled, phase 2 trial
Authors: Jeffrey Zwicker, Aaron Kithcart, Justin Kaplan, Poulabi Banerjee, Keshini Vyas, Dan Chalothorn, José Raya, Siyu Li, Laura Fredenburgh, Mihaela Mocan, Rosen Razboynikov, Lori Morton, David Gutstein, Kathryn Musgrave, Gregory Piazza
Other posts featuring Marc Carrier on Hemostasis Today.
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks